Persistence of humoral immune response to SARS-CoV-2 up to 7 months post-infection: Cross-sectional study, South India, 2020–21 - 26/08/21

Highlights |
• | Few studies are available about persistence of SARS-CoV-2 antibodies from LMICs. |
• | Anti-nucleocapsid antibodies waned over a 7 month period post SARS-CoV-2 infection. |
• | Anti S1-RBD antibodies were relatively stable. |
• | Neutralizing antibodies were persistent up to seven months post-infection. |
Vol 83 - N° 3
P. 381-412 - septembre 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.